Autolus Therapeutics Plc/ US05280R1005 /
| 5/22/2024 7:21:58 PM | Chg. -0.01 | Volume | Bid- | Ask7:24:00 PM | High | Low |
|---|---|---|---|---|---|---|
| 3.86USD | -0.26% | 6,161 Turnover: 23,615.89 |
-Bid Size: - | 3.86Ask Size: 100 | 3.89 | 3.79 |
GlobeNewswire
5/17
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire
5/14
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in ...
GlobeNewswire
5/13
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
GlobeNewswire
4/24
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of ob...
GlobeNewswire
4/23
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May ...
GlobeNewswire
4/2
Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the Europe...
GlobeNewswire
3/28
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientif...
GlobeNewswire
3/25
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Co...
GlobeNewswire
3/20
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire
3/14
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
GlobeNewswire
3/12
Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certificati...
GlobeNewswire
2/29
Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 20...
Newsfile Corp
2/15
Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
GlobeNewswire
2/8
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire
2/8
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
